PD-L1 positivity is observed in up to 65% of GC specimens [20], and even though it is widely associated with negative features, such as tumour size, lymph node metastasis and depth of invasion, there is no consensus on the role of PD-L1 expression as a prognostic biomarker in GC [23]. This evidence concerns the gene CD274 and neoplasm.